Biotechnology · Cambridge, MA · Founded 2021 · Privately Held (backing)
Developer of a biotechnological production platform intended to expand the reach of genome-editing-based therapies through the development of transformational biomaterials. Kano Therapeutics is based in Cambridge, MA and was founded in 2021. It was valued at $15 million at its seed round in Aug 2024, the last priced event on record. It has raised $7.4 million across 2 recorded rounds; the latest was a $5 million seed round in Aug 2024.
PMV mark · valuation
$15.0M
Oct 2026
Priced at
its seed round
Aug 2024
Total raised
$7.4M
Last round
Seed Round
Aug 2024
Cap table — not yet on record
Kano Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Kano Therapeutics with a free account
·The complete investor list: 12 names
·Watch Kano Therapeutics: the Monday email on marks, rounds and moves
Where does Kano Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Kano Therapeutics's 2 recorded funding rounds.
